Drugs / Dihydroxyvitamin D3
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00804050 | Mar 2007 → Mar 2009 | myelodysplastic syndrome | Fondazione Italiana Sindromi Mielodisplastiche-ETS | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dihydroxyvitamin D3 | “This is a prospective, randomized multicenter phase III clinical trial designed to evaluate the safety and activity of comparison between Erythropoietin and Erythropoietin...” NCT00804050 ↗ |
| Route | Oral | “Dihydroxyvitamin D3 (1 μg os/die)” NCT00804050 ↗ |